Le Lézard
Classified in: Health
Subject: FDA

Abbott Announces FDA Approval of the Alinitytm s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply

ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinitytm s System.  This new solution will bring the latest screening technology to U.S. blood and plasma centers. Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive systems. In a testing specialty that can require extensive hands-on time, the additional automation and flexibility of Alinity s will help blood and plasma centers improve productivity and maintain the highest levels of accuracy.

"Alinity s is a significant leap forward when it comes to speed, automation and efficiency for blood and plasma screening," said Louis Morrone, vice president, Transfusion Medicine, Abbott. "These elements are important to blood and plasma services of all sizes, supporting Abbott's overall mission to help people live longer, healthier lives by keeping the global blood and plasma supply safe."

Alinity s will help transform the blood and plasma screening process in terms of speed, capacity and "walk-away" time (i.e., when lab professionals are free to manage other responsibilities while the instrument processes samples) as a result of a number of new features:

"In order to ensure a safe blood and plasma supply, we need access to the most advanced technologies to screen donations," said Rachel-Louise Beddard, M.D., senior vice president and chief medical officer, QualTex Laboratories. "Alinity s will help us transform the way we conduct screening, so we can do our jobs most efficiently, allowing us to get the life-saving blood and plasma products to people facing their most critical situations."

About Alinity
Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostic platforms and simplifying diagnostic testing. Alinity systems are designed to be more efficient ? running more tests in less space, generating test results faster and minimizing human errors ? while continuing to provide quality results. The availability of the Alinity systems and tests varies by geography. More information is available at abbott.com/alinity.

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.



These press releases may also interest you

at 05:30
According to the new market research report "Pharmaceutical Membrane Filtration Market by Product (Filter, Systems), Technique (Microfiltration, Ultrafiltration), Material (PES, PVDF, PTFE, PCTE), Application (Final Product (Sterile), Raw Material...

at 05:15
The "Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report by Treatment (Medication, Surgery), by End Use (Hospitals, Clinics), and Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering. The...

at 05:05
The global tonometer market size is anticipated to reach USD 483.6 million by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 5.3% over the forecast period. Rapidly increasing geriatric population and improving...

at 05:00
The Pharmaceutical Contract Development and Manufacturing Market is expected to reach USD 126.6 billion by 2024 from an estimated USD 90.0 billion in 2019, at a CAGR of 7.1%.  The Pharmaceutical Contract Development and Manufacturing Market report...

at 05:00
Employee benefit administration company, Clarity Benefit Solutions, explains the importance of educating employees about benefits. For many employees, choosing the proper benefits plan can be an overwhelming and daunting process, especially for...

at 04:35
The global rhinoplasty market size is expected to reach USD 5.4 billion by 2026, exhibiting a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Factors such as rising awareness among people about physical...

News published on 11 july 2019 at 09:00 and distributed by: